Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 06/6/17 → 07/26/21 |
Funding
- Soligenix Incorporated: $51,803.34
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Flourescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma
- Kaufmann, Tara (CoPI)
- Lozeau, Daniel (CoPI)
- Lee, Yoojin (PI)
- Haughton, Adrienne (CoPI)
- Korzenko, Adam (CoPI)
Project: Research